The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to treat serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solution (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia.

The Abbott 3D Mapping System received FDA clearance in 2013 and is now in routine use at several leading medical centers throughout the United States.

Initial Human Experience of a Novel Steerable Sheath for AF Ablation with Circumferential PV Isolation

Initial Human Experience of a Novel Steerable Sheath for AF Ablation with Circumferential PV Isolation | EP Lab Digest

The Vado® Sheath was different from previous sheaths used at our institution, because the steerable design did not require pull-wires to create tip deflection. The 8.8F ID sheath design employs truVectorTM. Technology with a coaxial lumen, an inner shaft and outer shaft, bonded together at the distal tip and attached to two reference locations at the proximal end within the handle. Similar to existing steerable sheaths, tip deflection is achieved by rotating a knob on the sheath handle. In contrast to pull-wire designs, the Vado Sheath handle mechanism creates proximal tension on the inner shaft resulting in unilateral tip deflection since the two shafts are joined distally. This action pulls on the inner shaft, which causes tip deflection up to 270˚ (Figure 2). By eliminating pull-wires, the Vado Sheath provides stable tip deflection during catheter rotations and improves torque transfer to the distal catheter.

Read the entire article